|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 CAD | 0.00% |
|
0.00% | +400.00% |
| 26/04 | BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 08/02 | BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer | CI |
BioNeutra Global Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 2.99 million compared to CAD 3.93 million a year ago. Net loss was CAD 0.92478 million compared to net income of CAD 0.115917 million a year ago.
Basic loss per share from continuing operations was CAD 0.02. Diluted loss per share from continuing operations was CAD 0.02.
| 1st Jan change | Capi. | |
|---|---|---|
| +400.00% | 3.4M | |
| -2.39% | 275B | |
| -1.70% | 95.5B | |
| -2.00% | 44.01B | |
| +9.84% | 41.41B | |
| +1.40% | 41.13B | |
| +8.54% | 39.91B | |
| -12.79% | 31.14B | |
| -4.77% | 29.23B | |
| +14.15% | 25.26B |
BIONEUTRA GLOBAL CORPORATION 
